Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2a, Randomized, Partial Double-blind, Single Dose, Active-controlled, Dose Ranging Study to Evaluate the Safety of MEDI8852 in Adults With Acute, Uncomplicated Influenza

NCT02603952 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT02603952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02603952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2a, Randomized, Partial Double-blind, Single Dose, Active-controlled, Dose Ranging Study to Evaluate the Safety of MEDI8852 in Adults With Acute, Uncomplicated Influenza
Lead sponsor
MedImmune LLC
Phase
Phase 1/2
Overall status
Completed
Start date
December 7, 2015
Completion date
December 9, 2016
Enrollment
126 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

influenza